187 related articles for article (PubMed ID: 20394851)
1. Mature results of a randomized trial of accelerated hyperfractionated versus conventional radiotherapy in head-and-neck cancer.
Saunders MI; Rojas AM; Parmar MK; Dische S;
Int J Radiat Oncol Biol Phys; 2010 May; 77(1):3-8. PubMed ID: 20394851
[TBL] [Abstract][Full Text] [Related]
2. CHART revisited: a conservative approach for advanced head and neck cancer.
Saunders M; Rojas AM; Dische S
Clin Oncol (R Coll Radiol); 2008 Mar; 20(2):127-33. PubMed ID: 18065214
[TBL] [Abstract][Full Text] [Related]
3. Continuous accelerated 7-days-a-week radiotherapy for head-and-neck cancer: long-term results of phase III clinical trial.
Skladowski K; Maciejewski B; Golen M; Tarnawski R; Slosarek K; Suwinski R; Sygula M; Wygoda A
Int J Radiat Oncol Biol Phys; 2006 Nov; 66(3):706-13. PubMed ID: 17011446
[TBL] [Abstract][Full Text] [Related]
4. Radiation-free weekend rescued! Continuous accelerated irradiation of 7-days per week is equal to accelerated fractionation with concomitant boost of 7 fractions in 5-days per week: report on phase 3 clinical trial in head-and-neck cancer patients.
Skladowski K; Hutnik M; Wygoda A; Golen M; Pilecki B; Przeorek W; Rutkowski T; Lukaszczyk-Widel B; Heyda A; Suwinski R; Tarnawski R; Maciejewski B
Int J Radiat Oncol Biol Phys; 2013 Mar; 85(3):741-6. PubMed ID: 22836063
[TBL] [Abstract][Full Text] [Related]
5. Concomitant cisplatin significantly improves locoregional control in advanced head and neck cancers treated with hyperfractionated radiotherapy.
Huguenin P; Beer KT; Allal A; Rufibach K; Friedli C; Davis JB; Pestalozzi B; Schmid S; Thöni A; Ozsahin M; Bernier J; Töpfer M; Kann R; Meier UR; Thum P; Bieri S; Notter M; Lombriser N; Glanzmann C
J Clin Oncol; 2004 Dec; 22(23):4665-73. PubMed ID: 15534360
[TBL] [Abstract][Full Text] [Related]
6. Accelerated hyperfractionated irradiation with concomitant boost for stage II laryngeal cancer and locally advanced head and neck cancer.
Ishii K; Tashiro M; Hosono M; Fukuda H; Takada Y; Kondo S; Inoue Y; Iguchi H; Kusuki M; Yamane H
Acta Otolaryngol Suppl; 2004 Oct; (554):62-6. PubMed ID: 15513514
[TBL] [Abstract][Full Text] [Related]
7. Hyperfractionated accelerated radiotherapy alone and with concomitant chemotherapy to the head and neck: treated within and outside of randomized clinical trials.
Hehr T; Classen J; Schreck U; Glocker S; Bamberg M; Budach W
Int J Radiat Oncol Biol Phys; 2004 Apr; 58(5):1424-30. PubMed ID: 15050319
[TBL] [Abstract][Full Text] [Related]
8. Preoperative hyperfractionated accelerated radiotherapy and radical surgery in advanced head and neck cancer: a prospective phase II study.
Lindholm P; Valavaara R; Aitasalo K; Kulmala J; Laine J; Elomaa L; Sillanmäki L; Minn H; Grénman R
Radiother Oncol; 2006 Feb; 78(2):146-51. PubMed ID: 16307813
[TBL] [Abstract][Full Text] [Related]
9. Hypofractionated radiotherapy denoted as the "Christie scheme": an effective means of palliating patients with head and neck cancers not suitable for curative treatment.
Al-mamgani A; Tans L; Van rooij PH; Noever I; Baatenburg de jong RJ; Levendag PC
Acta Oncol; 2009; 48(4):562-70. PubMed ID: 19373698
[TBL] [Abstract][Full Text] [Related]
10. Simultaneous integrated boost intensity-modulated radiotherapy for locally advanced head-and-neck squamous cell carcinomas: II--clinical results.
Lauve A; Morris M; Schmidt-Ullrich R; Wu Q; Mohan R; Abayomi O; Buck D; Holdford D; Dawson K; Dinardo L; Reiter E
Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):374-87. PubMed ID: 15380569
[TBL] [Abstract][Full Text] [Related]
11. Molecular marker profiles predict locoregional control of head and neck squamous cell carcinoma in a randomized trial of continuous hyperfractionated accelerated radiotherapy.
Buffa FM; Bentzen SM; Daley FM; Dische S; Saunders MI; Richman PI; Wilson GD
Clin Cancer Res; 2004 Jun; 10(11):3745-54. PubMed ID: 15173081
[TBL] [Abstract][Full Text] [Related]
12. Repair halftimes estimated from observations of treatment-related morbidity after CHART or conventional radiotherapy in head and neck cancer.
Bentzen SM; Saunders MI; Dische S
Radiother Oncol; 1999 Dec; 53(3):219-26. PubMed ID: 10660202
[TBL] [Abstract][Full Text] [Related]
13. Does radiation dose to the salivary glands and oral cavity predict patient-rated xerostomia and sticky saliva in head and neck cancer patients treated with curative radiotherapy?
Jellema AP; Doornaert P; Slotman BJ; Leemans CR; Langendijk JA
Radiother Oncol; 2005 Nov; 77(2):164-71. PubMed ID: 16256229
[TBL] [Abstract][Full Text] [Related]
14. Chemoradiation for advanced head and neck cancer: potential for improving results to match those of current treatment modalities for early-stage tumors--long-term results of hyperfractionated chemoradiation with carbogen breathing and anemia correction with erythropoietin.
Villar A; Martinez JC; de Serdio JL
Int J Radiat Oncol Biol Phys; 2008 Apr; 70(5):1382-8. PubMed ID: 18037586
[TBL] [Abstract][Full Text] [Related]
15. Concomitant administration of two standard regimens of chemotherapy and radiotherapy in advanced squamous carcinoma of the head and neck: a feasibility study.
Benasso M; Corvò R; Numico G; Cavallari M; Blengio F; Sanguineti G; Rosso M; Merlano M
Anticancer Res; 1995; 15(6B):2651-4. PubMed ID: 8669841
[TBL] [Abstract][Full Text] [Related]
16. Carboplatin and radiotherapy in the treatment of head and neck cancer: six years' experience.
Zamboglou N; Schnabel T; Kolotas C; Achterrath W; Strehl H; Dalhäuser S; Vogt HG; Lenaz L; Schmitt G
Semin Oncol; 1994 Oct; 21(5 Suppl 12):45-53. PubMed ID: 7992066
[TBL] [Abstract][Full Text] [Related]
17. Advanced head and neck carcinoma in women: treatment outcomes may not improve with accelerated hyperfractionated radiotherapy.
Leborgne F; Leborgne JH; Fowler JF; Zubizarreta E; Mezzera J
Cancer; 2001 Jun; 91(12):2353-60. PubMed ID: 11413525
[TBL] [Abstract][Full Text] [Related]
18. Toxic cure: Hyperfractionated radiotherapy with concurrent cisplatin and fluorouracil for Stage III and IVA head-and-neck cancer in the community.
Maguire PD; Meyerson MB; Neal CR; Hamann MS; Bost AL; Anagnost JW; Ungaro PC; Pollock HD; McMurray JE; Wilson EP; Kotwall CA
Int J Radiat Oncol Biol Phys; 2004 Mar; 58(3):698-704. PubMed ID: 14967423
[TBL] [Abstract][Full Text] [Related]
19. Concomitant boost radiotherapy compared with conventional radiotherapy in squamous cell carcinoma of the head and neck--a phase III trial from a single institution in India.
Ghoshal S; Goda JS; Mallick I; Kehwar TS; Sharma SC
Clin Oncol (R Coll Radiol); 2008 Apr; 20(3):212-20. PubMed ID: 18343310
[TBL] [Abstract][Full Text] [Related]
20. A dose escalation study of hyperfractionated accelerated radiation delivered with integrated neck surgery (HARDWINS) for the management of advanced head and neck cancer.
Waldron J; Warde P; Irish J; Pintilie M; Sellmann S; Bayley A; Cummings B; Kim J; Liu FF; Payne D; Ringash J; Brown D; Freeman J; Gilbert R; Gullane P; Witterick I; O'Sullivan B
Radiother Oncol; 2008 May; 87(2):173-80. PubMed ID: 18342965
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
